The safety and clinical effects of administering a multiantigen-targeted T cell therapy to patients with multiple myeloma.
Lulla PD, Tzannou I, Vasileiou S, Carrum G, Ramos CA, Kamble R, Wang T, Wu M, Bilgi M, Gee AP, Mukhi S, Chung B, Wang L, Watanabe A, Kuvalekar M, Jeong M, Li Y, Ketkar S, French-Kim M, Grilley B, Brenner MK, Heslop HE, Vera JF, Leen AM.
Lulla PD, et al. Among authors: carrum g.
Sci Transl Med. 2020 Jul 29;12(554):eaaz3339. doi: 10.1126/scitranslmed.aaz3339.
Sci Transl Med. 2020.
PMID: 32727914